Year To Quarter End Consolidated Statement Of Comprehensive Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7734955

Concept 2017-04-01 to
2017-06-30
2016-04-01 to
2016-06-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
5,463,000,000 JPY
5,796,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
725,000,000 JPY
-748,000,000 JPY
Remeasurements of defined benefit plans, net of tax
111,000,000 JPY
109,000,000 JPY
Other comprehensive income
836,000,000 JPY
-638,000,000 JPY
Comprehensive income
6,300,000,000 JPY
5,158,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
6,300,000,000 JPY
5,158,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.